| Literature DB >> 21272341 |
Hung-Ming Wu1, Wan-Yu Huang, Meng-Luen Lee, Albert D Yang, Ko-Ping Chaou, Lin-Yu Hsieh.
Abstract
BACKGROUND: Salmonella meningitis remains a threat to children below two years of age in both developing and developed countries. However, information on such infections has not been well characterized. We analyzed data related to twelve years of experience in order to clarify the comprehensive features of Salmonella meningitis in our patients, including admission characteristics, acute complications, and long-term outcome.Entities:
Mesh:
Year: 2011 PMID: 21272341 PMCID: PMC3039577 DOI: 10.1186/1471-2334-11-30
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Admission features and progress of the twenty-four patients with Salmonella meningitis
| Characteristics | Cases (N = 24) n (%) |
|---|---|
| Male: Female | 15: 9 |
| Age at onset, days* | 79 ± 44.5 (range, 5 to 266) |
| Onset of symptoms before admission, days* | 2.1 ± 0.74 (range,1 to 3) |
| Clinical features present between onset of symptoms and day of diagnosis | |
| Fever | 24 (100) |
| Lethargy | 6 (25) |
| Irritability | 10 (42) |
| Poor feeding | 20 (83) |
| Diarrhea | 8 (33) |
| Vomiting | 9 (38) |
| Bulging anterior fontanel | 13 (54) |
| Nuchal rigidity | 9 (38) |
| Seizure | 15 (63) |
| CSF | 24 (100) |
| Blood | 13 (59) |
| Stool | 3 (17) |
| Urine | 1 (6) |
| Antibiotics | |
| CM | 1(4) |
| AC, CM | 2 (8) |
| AC, third-generation cephalosporins | 6 (25) |
| CM, third-generation cephalosporins | 4 (17) |
| AC, CM, third-generation cephalosporins | 2 (8) |
| AG, third-generation cephalosporins | 2 (8) |
| Third-generation cephalosporins | 7 (29) |
| Duration of hospitalization, days* | 32.1 ± 12.2 (range, 14 to 74) |
| Condition at discharge | |
| Survival | 21 (88) |
| No disability | 8 (33) |
| Disability | 13 (54) |
| Ongoing seizure | 7 (29) |
| Focal motor weakness | 10 (42) |
| Cranial nerve palsy | 2 (8) |
| Death | 3 (13) |
| Relapse | 1 (4) |
*Values are presented as mean ± SD with range in parentheses; n (%), case number with percentage of the patients with positive findings in parentheses; #Denotes CSF cultures done in 24 cases, blood cultures in 22, urine cultures in 16, and stool cultures in 18; third-generation cephalosporins: cefotaxime, moxalaxtam, ceftriaxone, and ceftazidime; AC, Ampicllin; AG, aminoglycoside; CM, Chloramphenicol; disability, impairment of physical ability and seizure.
Analysis of peripheral leukocytes and CSF at the time of diagnosis
| Findings | Cases (N = 24) n (%) |
|---|---|
| Peripheral blood data | |
| Total WBC/μl* | 12210 (1570-28900) |
| Segmented WBC/μl* | 4760 (527-17138) |
| Banded WBC/μl* | 389 (0-4624) |
| Platelet (×104/μl)* | 32.7 (7.4-87.5) |
| CSF data | |
| Total WBC/μl* | 1852 (68-30600) |
| PMN/μl* | 1490 (65-24480) |
| Glucose (mg/L)* | 15 (0-69) |
| Protein (mg/dl)* | 330 (40-740) |
| CSF/blood glucose ratio < 0.5 | 20 (83) |
| CSF protein > 200 mg/dl | 13 (54) |
| Gram stain positive | 24 (100) |
* Values are presented as median (complete range); WBC, white blood cell; PMNs, polymorphonuclear leukocytes.
The association of clinic features, CSF findings, and acute complications with the outcome in twenty-four children with Salmonella meningitis
| Variable | Death, moderate and severe sequelae group (N = 15) n (%) | Mild sequelae and good outcome group (N = 9) n (%) |
|---|---|---|
| Level of consciousness | ||
| Lethargy or irritability at admission* | 13 (87) | 3 (33) |
| Coma in hospital#* | 10 (67) | 0 (0) |
| Seizures | ||
| Seizure before admission | 10 (67) | 5 (56) |
| Seizure in hospital* | 12 (80) | 1 (11) |
| Laboratory tests | ||
| CSF: blood glucose < 0.5* | 15 (100) | 5 (56) |
| CSF protein > 200 mg/dl* | 11 (73) | 2 (22) |
| Intracranial complications | ||
| Subdural collection | 6 (40) | 4 (44) |
| Intracranial focal infection* | 5 (33) | 0 (0) |
| Empyema | 3 (20) | 0 (0) |
| Brain abscess | 2 (13) | 0 (0) |
| Cerebral infarction* | 8 (53) | 0 (0) |
| Ventriculitis* | 6 (40) | 0 (0) |
| Hydrocephalus | 9 (60) | 3 (33) |
*Denotes a significant difference between death, moderate and severe sequelae group and mild adverse and good outcome group in the univariate analysis using Fischer's exact test (p < 0.05); #Denotes Grady coma scale IV and V.
Long-term outcome associated with acute main complications for Salmonella meningitis in twenty-one survivors
| Findings | Survivors (N = 21) n/total (%)* | Number of acute main complications in each particular outcome | ||||||
|---|---|---|---|---|---|---|---|---|
| Seizure# | Sudural effusion | Hydro- cephalus | Ventr-iculitis | Em-pyema | Brain abcess | Cerebral infarction | ||
| Development | ||||||||
| Delayed | 14/21 (67) | 11 | 5 | 8 | 5 | 3 | 2 | 7 |
| Normal | 7/21 (23) | 0 | 4 | 3 | 0 | 0 | 0 | 0 |
| Motor disability | ||||||||
| Severe | 5/21 (24) | 5 | 2 | 5 | 5 | 1 | 2 | 3 |
| Moderate | 4/21 (19) | 3 | 3 | 1 | 0 | 1 | 0 | 4 |
| Mild | 1/21 (5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Normal | 11/21 (52) | 3 | 4 | 4 | 0 | 1 | 0 | 0 |
| Hearing Problems | 3/18 (17) | 2 | 1 | 3 | 1 | 1 | 1 | 0 |
| Epilepsy | 7/21 (33) | 6 | 2 | 4 | 4 | 3 | 2 | 5 |
| Microcephaly | 1/21 (5) | 1 | 0 | 1 | 1 | 0 | 1 | 1 |
| Hydrocephalus | 1/21 (5) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Visual deficit | 2/21 (10) | 1 | 2 | 1 | 0 | 0 | 0 | 1 |
| CN6 palsy | 1/21 (5) | 0 | 1 | 1 | 0 | 0 | 0 | 0 |
| Intelligence | ||||||||
| IQ < 55 | 6/21 (29) | 6 | 2 | 5 | 5 | 2 | 2 | 4 |
| IQ 55-69 | 1/21 (5) | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
| IQ 70-80 | 2/21 (10) | 1 | 1 | 1 | 0 | 0 | 0 | 1 |
| IQ > 80 | 12/21 (57) | 3 | 6 | 5 | 0 | 0 | 0 | 2 |
| Speech/language | ||||||||
| Abnormal | 11/21 (52) | 9 | 4 | 7 | 5 | 3 | 2 | 6 |
| Normal | 10/21 (48) | 2 | 5 | 4 | 0 | 0 | 0 | 1 |
*Values are expressed as number of patients with each particular outcome/number of patients examined, and numbers in parentheses are percentages; #Seizure in hospital; CN6, Abducens nerve palsy; MR, mental retardation; IQ, intelligence quotient.